HomeCompareNNMTF vs PFE

NNMTF vs PFE: Dividend Comparison 2026

NNMTF yields 40.50% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NNMTF wins by $4.8K in total portfolio value
10 years
NNMTF
NNMTF
● Live price
40.50%
Share price
$0.95
Annual div
$0.38
5Y div CAGR
-20%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$55.9K
Annual income
$1,208.76
Full NNMTF calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — NNMTF vs PFE

📍 NNMTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNNMTFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NNMTF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NNMTF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NNMTF
Annual income on $10K today (after 15% tax)
$3,442.41/yr
After 10yr DRIP, annual income (after tax)
$1,027.45/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, PFE beats the other by $22,101.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NNMTF + PFE for your $10,000?

NNMTF: 50%PFE: 50%
100% PFE50/50100% NNMTF
Portfolio after 10yr
$53.5K
Annual income
$14,209.65/yr
Blended yield
26.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

NNMTF
No analyst data
Altman Z
3.5
Piotroski
8/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NNMTF buys
0
PFE buys
0
No recent congressional trades found for NNMTF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNNMTFPFE
Forward yield40.50%6.20%
Annual dividend / share$0.38$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-20%13.2%
Portfolio after 10y$55.9K$51.1K
Annual income after 10y$1,208.76$27,210.54
Total dividends collected$24.8K$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NNMTF vs PFE ($10,000, DRIP)

YearNNMTF PortfolioNNMTF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$13,940$3,239.92$9,161$701.38+$4.8KNNMTF
2$18,292$3,376.76$8,610$859.79+$9.7KNNMTF
3$22,886$3,312.98$8,366$1,081.25+$14.5KNNMTF
4$27,587$3,098.99$8,483$1,405.66+$19.1KNNMTF
5$32,311$2,792.94$9,084$1,907.24+$23.2KNNMTF
6$37,018$2,445.76$10,418$2,732.78+$26.6KNNMTF
7$41,705$2,095.03$13,007$4,193.56+$28.7KNNMTF
8$46,389$1,764.67$18,010$7,005.87+$28.4KNNMTF
9$51,104$1,467.56$28,216$12,979.89+$22.9KNNMTF
10$55,890$1,208.76$51,081$27,210.54+$4.8KNNMTF

NNMTF vs PFE: Complete Analysis 2026

NNMTFStock

Nine Entertainment Co. Holdings Limited engages in the broadcasting and program production businesses across free to air television, video on demand, and metropolitan radio networks in Australia. It operates through Broadcasting, Digital and Publishing, Domain Group, and Stan segments. The company provides television services under the brands, including 9Network, Channel 9, 9Gem, 9Go!, 9Life, and 9Rush; video on demand platform under 9Now brand; radio stations under 2GB, 3AW, 4BC, and 6PR brands; and publishes newspapers, news-inserted magazines, digital, and events, as well as nine.com.au, a site of news, lifestyle, sport, and entertainment content. It also offers mastheads under The Sydney Morning Herald, The Age, The Australian Financial Review, Brisbane Times, WAtoday, The Sun-Herald, and The Sunday Age brands. In addition, the company provides real estate media and technology services. Nine Entertainment Co. Holdings Limited was founded in 1956 and is headquartered in North Sydney, Australia.

Full NNMTF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this NNMTF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NNMTF vs SCHDNNMTF vs JEPINNMTF vs ONNMTF vs KONNMTF vs MAINNNMTF vs JNJNNMTF vs MRKNNMTF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.